Zhejiang Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05779514
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Radiomics-based Malnutrition for Cervical Cancer.
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT05709769
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05613465
- Locations
- 🇨🇳
Zhejiang Provincial People'S Hospital, Hangzhou, Other (Non U.s.), China
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT05451615
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 634
- Registration Number
- NCT05446441
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05446467
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
🇨🇳Tianjin Cancer Hospital Airport Hospital, Tianjin, China
🇨🇳Sir Run Run Shaw Hospital School of Medicine,Zhejiang University, Hangzhou, China
Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT05089942
- Locations
- 🇨🇳
Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
Not yet recruiting
- Conditions
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2021-04-30
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT04866667
Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04810910
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
A Modified Omental Patch Work Decreases Pancreatic Fistula After Lpd
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 162
- Registration Number
- NCT04704882
- Locations
- 🇨🇳
Zhejiang Provincial People'S Hospital, Hangzhou, Zhejiang, China
© Copyright 2024. All Rights Reserved by MedPath